You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Morristown Protocol

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)

Completed
Has Results
  • Colitis, Ulcerative
  • Inflammatory Bowel Diseases
  • Placebo IV
  • +3 more
  • Birmingham, Alabama
  • +253 more
Jan 3, 2023

National Cancer Institute "Cancer Moonshot Biobank"

Recruiting
  • Acute Myeloid Leukemia
  • +33 more
  • Biospecimen Collection
  • Medical Chart Review
  • Kingman, Arizona
  • +99 more
Nov 3, 2022

Gastroesophageal Reflux Disease (GERD) Trial in Canada, United States (IW-3718, , Standard-dose PPIs QD)

Completed
Has Results
  • Gastroesophageal Reflux Disease (GERD)
  • Birmingham, Alabama
  • +100 more
Jul 23, 2021

Post Extubation Dysphagia Trial in Morristown (Ice chips)

Recruiting
  • Post Extubation Dysphagia
  • Ice chips
  • Morristown, New Jersey
    Morristown Medical Center
Aug 12, 2022

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Musculoskeletal Diseases, Soft Tissue Mass Trial in Morristown (Exparel Injectable Product, Multi-Drug Cocktail (Ropivicaine,

Recruiting
  • Musculoskeletal Diseases
  • Soft Tissue Mass
  • Exparel Injectable Product
  • Multi-Drug Cocktail (Ropivicaine, Epinephrine, Ketolorac, Clonidine)
  • Morristown, New Jersey
    Morristown Medical Center
Apr 27, 2022

Advanced Solid Cancers, Advanced Solid Cancers Refractory to PD-1 Trial in United States (AGEN1884)

Completed
  • Advanced Solid Cancers
  • Advanced Solid Cancers Refractory to PD-1
  • Duarte, California
  • +10 more
Apr 28, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Glycogen Storage Disease Type II, Pompe Disease Trial in Worldwide

Recruiting
  • Glycogen Storage Disease Type II
  • Pompe Disease
    • Birmingham, Alabama
    • +274 more
    Jan 12, 2023

    Prevalence of OSA in Patients Hospitalized With COPD Exacerbation Trial (WatchPAT)

    Not yet recruiting
    • Prevalence of OSA in Patients Hospitalized With COPD Exacerbation
    • WatchPAT
    • (no location specified)
    Sep 8, 2021

    Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

    Recruiting
    • Endometrial Cancer
    • Atezolizumab - 28 Day Cycle
    • +6 more
    • Duarte, California
    • +13 more
    Jun 8, 2022

    Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)

    Not yet recruiting
    • Limited Stage Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • Minneapolis, Minnesota
    • +124 more
    Oct 31, 2023

    Aortic Aneurysm, Abdominal Trial in United States (Endurant Stent Graft System)

    Completed
    Has Results
    • Aortic Aneurysm, Abdominal
    • Endurant Stent Graft System
    • Los Angeles, California
    • +23 more
    Oct 27, 2021

    Infection, Enterocolitis, Necrotizing, Ventilator-associated Pneumonia Trial in United States (oropharyngeal mother's milk,

    Active, not recruiting
    • Infection
    • +2 more
    • oropharyngeal mother's milk
    • oropharyngeal sterile water
    • Miami, Florida
    • +4 more
    Apr 8, 2022

    Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff Trial in Canada, United States (CP101)

    Completed
    Has Results
    • Clostridium Difficile Infection
    • +10 more
    • CP101
    • Scottsdale, Arizona
    • +56 more
    Aug 10, 2022

    Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

    Recruiting
    • Squamous-Cell Non-Small-Cell Lung Cancer
    • Orange, California
    • +24 more
    Jul 27, 2022

    Ulcerative Colitis Trial in Worldwide (tofacitinib)

    Recruiting
    • Ulcerative Colitis
    • Phoenix, Arizona
    • +92 more
    Jan 25, 2023

    NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sasanlimab Prefilled syringe
    • +5 more
    • Duarte, California
    • +96 more
    Jan 18, 2023

    Crohn's Disease, Complex Perianal Fistula Trial in Worldwide (Darvadstrocel)

    Active, not recruiting
    • Crohn's Disease
    • Complex Perianal Fistula
    • Darvadstrocel
    • San Francisco, California
    • +77 more
    Jan 18, 2023

    Clinical, Imaging, and Endoscopic Outcomes of Children Newly

    Not yet recruiting
    • Crohn Disease
    • infliximab, adalimumab
    • Phoenix, Arizona
    • +26 more
    Mar 10, 2023

    Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

    Active, not recruiting
    • Ganglioneuroblastoma, Nodular
    • Neuroblastoma
    • Dinutuximab
    • +4 more
    • Mesa, Arizona
    • +77 more
    Aug 17, 2022

    Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

    Recruiting
    • Metastatic Cancer
    • +2 more
    • ASP9801
    • Pembrolizumab
    • Birmingham, Alabama
    • +26 more
    Jan 6, 2023

    Ovarian Tumors, Breast Tumors Trial in Worldwide (Niraparib)

    Active, not recruiting
    • Ovarian Neoplasms
    • Breast Neoplasms
    • Tucson, Arizona
    • +22 more
    Jul 20, 2022

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023